XML 62 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Goodwill and Other Intangible Assets (Tables)
3 Months Ended
Jul. 29, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes in the Carrying Amount of Goodwill
The following table presents the changes in the carrying amount of goodwill by segment:
(in millions)CardiovascularMedical SurgicalNeuroscienceDiabetesTotal
April 29, 2022$7,160 $19,957 $11,132 $2,254 $40,502 
Goodwill as a result of acquisitions66 — 615 — 680 
Purchase accounting adjustments(10)— — — (10)
Transfer to held for sale— (208)— — (208)
Currency translation and other(49)(507)(83)(1)(640)
July 29, 2022$7,166 $19,242 $11,664 $2,253 $40,324 
Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets
The following table presents the gross carrying amount and accumulated amortization of intangible assets:
July 29, 2022April 29, 2022
(in millions)Gross Carrying AmountAccumulated AmortizationGross Carrying AmountAccumulated Amortization
Definite-lived:
Customer-related$16,927 $(7,238)$16,953 $(7,005)
Purchased technology and patents11,311 (5,758)10,802 (5,667)
Trademarks and tradenames485 (268)473 (266)
Other97 (65)80 (69)
Total$28,820 $(13,328)$28,308 $(13,006)
Indefinite-lived:
IPR&D$283 $— $293 $— 
Gross Carrying Amount of Indefinite-Lived Intangible Assets
The following table presents the gross carrying amount and accumulated amortization of intangible assets:
July 29, 2022April 29, 2022
(in millions)Gross Carrying AmountAccumulated AmortizationGross Carrying AmountAccumulated Amortization
Definite-lived:
Customer-related$16,927 $(7,238)$16,953 $(7,005)
Purchased technology and patents11,311 (5,758)10,802 (5,667)
Trademarks and tradenames485 (268)473 (266)
Other97 (65)80 (69)
Total$28,820 $(13,328)$28,308 $(13,006)
Indefinite-lived:
IPR&D$283 $— $293 $— 
Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at July 29, 2022, excluding any possible future amortization associated with acquired IPR&D which has not yet met technological feasibility, is as follows:
(in millions)Amortization Expense
Remaining 2023$1,261 
20241,649 
20251,627 
20261,613 
20271,589 
20281,539